Wed, August 26, 2026
|
CannabisInsightKorea's Cannabis Business & Policy Media

Korean Cannabis Legislation입법동향

Tracking cannabis, hemp, and CBD-related bills in the Korean National Assembly — proposal status and committee review progress.

Bill No. 2217773Committee Review

Partial Amendment to the Act on the Control of Narcotics

Rep. 서미화 et al. (10 co-sponsors) · Proposed 2026-03-26 · Health and Welfare Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

This bill would classify cannabis-derived components with medical utility, including CBD, as psychotropic medicines, enabling domestic manufacture and marketing authorization. It would also create a licensing framework for cannabis cultivation for medical purposes, clarify the statutory definition of cannabis in line with Supreme Court case 2022du60776, and establish a designated raw-material management support center for medical narcotics.

Key Provisions

  • ✓Classifies CBD and other cannabis-derived components as psychotropic medicines, allowing domestic drug manufacture and marketing authorization
  • ✓Expands the definition of medical-purpose cannabis cultivators and creates an MFDS licensing procedure
  • ✓Creates a designated raw-material management support center for medical narcotics
  • ✓Clarifies that CBD falls within the legal definition of cannabis, reflecting Supreme Court precedent
#CBD#Medical Cannabis#Act on the Control of Narcotics#Domestic Manufacturing
Bill No. 2217027Committee Review

Special Act on Fostering the Hemp Industry and Ensuring Hemp Safety

Rep. 윤준병 et al. (11 co-sponsors) · Proposed 2026-02-25 · Agriculture, Food, Rural Affairs, Oceans and Fisheries Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

A dedicated hemp statute that would define cannabis below a specified THC threshold as hemp and establish a safety-management framework for cultivation, processing, distribution and sale. It would create a legal basis for hemp applications in medical, food and industrial sectors, while building industry infrastructure through a Hemp Industry Promotion Institute and designated hemp clusters.

Key Provisions

  • ✓Defines hemp separately from narcotics for cannabis below the statutory THC threshold
  • ✓Introduces licensing for hemp cultivation, breeding, manufacturing and sales, involving both agriculture and food-safety authorities
  • ✓Establishes a Hemp Industry Promotion Institute and a five-year comprehensive plan
  • ✓Creates a designation system for regional hemp industry clusters
  • ✓Builds a hemp traceability-management system led by the Ministry of Food and Drug Safety
#Hemp#Hemp Special Act#Industry Promotion#Cultivation License#Hemp Industry Promotion Institute
Bill No. 2219769Committee Review

Partial Amendment to the Act on the Control of Narcotics

Rep. 김형동 et al. (13 co-sponsors) · Proposed 2026-07-06 · Health and Welfare Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

This bill would classify medically useful cannabis-derived components, including CBD, as psychotropic medicines and permit domestic manufacture. It would create a licensing framework for medical cannabis cultivators and establish a state-led raw-material management center for medical narcotics, overseeing the supply chain from cultivation through extraction, manufacturing and allocation.

Key Provisions

  • ✓Classifies CBD and other cannabis-derived components as psychotropic medicines, allowing domestic drug manufacture and marketing authorization
  • ✓Creates an MFDS licensing framework for medical-purpose cannabis cultivation
  • ✓Establishes a state-led raw-material management center for medical narcotics
  • ✓Sets up state oversight from cultivation and extraction through manufacturing and raw-material allocation
#CBD#Medical Cannabis#Act on the Control of Narcotics#Domestic Manufacturing#Raw-Material Management Center
Bill No. 2219780Committee Review

Partial Amendment to the Act on the Control of Narcotics

Rep. 신성범 et al. (10 co-sponsors) · Proposed 2026-07-06 · Health and Welfare Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

This bill would exclude hemp containing no more than 0.3% THC by dry weight from the statutory definition of cannabis, enabling lawful use across medical, functional-food, cosmetics, textile and feed sectors. It reflects WHO recommendations and the UN Commission on Narcotic Drugs decision on cannabis scheduling, while extending the industrialization model demonstrated in the Gyeongbuk Hemp Regulatory Free Zone nationwide.

Key Provisions

  • ✓Excludes hemp containing no more than 0.3% THC from the statutory definition of cannabis
  • ✓Allows lawful use in medical, functional-food, cosmetics, textile, feed and other sectors
  • ✓Reflects WHO recommendations and the UN Commission on Narcotic Drugs decision in domestic law
  • ✓Extends the Gyeongbuk Hemp Regulatory Free Zone model into a nationwide framework
#Hemp#THC 0.3%#Act on the Control of Narcotics#Cannabis Exclusion#Industrialization

This page is based on publicly available data from the Korean National Assembly Bill Information System. Legislative status may not reflect real-time updates. For the latest information, please visit the National Assembly Bill Information System.